🔎 Trials Near Me

Dachaigh › Galar Crohn › Texas › Tyler

Sgrùdaidhean clionaigeach Galar Crohn ann an Tyler, TX

Tha 17 sgrùdaidhean airson Galar Crohn a’ lorg phàirtichean aig làraichean ann agus timcheall air Tyler (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.

Teacsa sgrùdaidh oifigeil (Beurla)

A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →

Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis

A’ fastadhÌre 2
  • Tyler Research Institute /ID# 284247, Tyler
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 5 Dàmh 2026 · NCT07697456

Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)

A’ fastadhÌre 3
  • Tyler Research Institute ( Site 0294), Tyler
Gach aois · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT06651281

A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)

A’ fastadhÌre 3
  • Tyler Research Institute ( Site 5001), Tyler
Aoisean 16 gu 80 · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT06430801

Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease

A’ fastadhÌre 2
  • Tyler Research Institute /ID# 265545, Tyler
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT06548542

A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease

A’ fastadhÌre 2
  • Tyler Research Institute, LLC, Tyler
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT06233461

A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease

A’ fastadhÌre 3
  • The University of Texas Health Science Center at Tyler, Tyler
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT07499232

A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease

A’ fastadhÌre 2/3
  • Tyler Research Institute, LLC, Tyler
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT07196722

Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

A’ fastadhÌre 3
  • Tyler Research Institute, Tyler
Aoisean 18 gu 70 · Gach gnè · Air ùrachadh 24 Sult 2026 · NCT06937099

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

A’ fastadhÌre 3
  • Tyler Research Institute, LLC-Site Number: 8400095, Tyler
Aoisean 16 gu 80 · Gach gnè · Air ùrachadh 23 Sult 2026 · NCT07184931

A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

A’ fastadhÌre 3
  • Tyler Research Institute LLC-Site Number: 8400095, Tyler
Aoisean 16 gu 80 · Gach gnè · Air ùrachadh 23 Sult 2026 · NCT07184944

A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease

A’ fastadhÌre 2
  • Tyler Research Institute, LLC, Tyler
Aoisean 18 gu 85 · Gach gnè · Air ùrachadh 22 Sult 2026 · NCT06226883

A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease

A’ fastadhÌre 4
  • Tyler Research Institute, LLC, Tyler
Aoisean 18 gu 70 · Gach gnè · Air ùrachadh 9 Sult 2026 · NCT06045754

A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease

A’ fastadhÌre 3
  • Tyler Research Institute, LLC, Tyler
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 28 Lùna 2026 · NCT07577843

A Study of Vedolizumab With and Without Upadacitinib in Adults With Crohn's Disease

A’ fastadhÌre 3
  • Tyler Research Institute, LLC, Tyler
Aoisean 18 gu 65 · Gach gnè · Air ùrachadh 27 Cèit 2026 · NCT06227910

A Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn's Disease (CD)

A’ fastadhÌre 2
  • Tyler Research Institute, LLC, Tyler
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 22 Cèit 2026 · NCT06764615

Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease

A’ fastadhÌre 2
  • Tyler Research Institute, LLC, Tyler
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 27 Gibl 2026 · NCT06456593

A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease

A’ fastadhÌre 2
  • Mirador Therapeutics Selected Site, Tyler
Aoisean 18 gu 80 · Gach gnè · Air ùrachadh 12 Màrt 2026 · NCT07113522

Sgrùdaidhean Galar Crohn ann am bailtean eile

Sgrùdaidhean eile ann an Tyler

Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.